User:Paul Anders Fronth Nyhus: Difference between revisions
| (13 intermediate revisions by the same user not shown) | |||
| Line 5: | Line 5: | ||
*Paul Anders Fronth Nyhus | *Paul Anders Fronth Nyhus | ||
*NorBioS | *NorBioS | ||
*SynBiOSyS | |||
*Norwegian.Igem.Team | |||
*Europe | *Europe | ||
*[[Special:Emailuser/Paul Anders Fronth Nyhus|Email me through OpenWetWare]] | *[[Special:Emailuser/Paul Anders Fronth Nyhus|Email me through OpenWetWare]] | ||
I work in the [Open LAB ] at XYZ University. I learned about [[OpenWetWare]] from The Longnow Foundation, and I've joined because I deem it necessary and warranted to establish a framework and voluntary | I work in the [Open LAB ] at XYZ University. I learned about [[OpenWetWare]] from The Longnow Foundation, and I've joined because I deem it necessary and warranted to establish a coherent analytical framework for understanding the long term risks in relation to genetic engeneering and voluntary codes of conduct for dealing proactively with Biorisks , Biosafety , Biosecurity and Biodiversity Acces Benefit Sharing issues in Synthetic Biology Metabolic engennering Combinatorial Genomics and genome editing .Herein included Economic, Ethical, Legal and Social Issues as to maximize benefits ( for whom ? ) and minimize potential negative risks and unintended consequences if not sheer luddism and complete rejection from civil society. | ||
Discussing the options by inclusion and involvement of stakeholders sui generis: | Discussing the options by inclusion and involvement of stakeholders sui generis:Cui Bene | ||
==Education== | ==Education== | ||
| Line 21: | Line 23: | ||
==Research interests== | ==Research interests== | ||
<!-- Feel free to add brief descriptions to your research interests as well --> | <!-- Feel free to add brief descriptions to your research interests as well --> | ||
# Comparative genomics of Aquaporins | # Comparative genomics of Aquaporins and gene regulation | ||
# Comparative genomics proteomics and metabolomics of | # BioPatways2Bioprocess Green Chemistry Cell Free Systems and scaffolds | ||
# Comparative genomics of gene regulatory networks | # MarineMicrobiomics Comparative genomics proteomics and metabolomics of Photosynthesis /E-Photosynthesis /Quantum Effects in Biology | ||
# Evolution & Development & Ecology ( Evo Devo Evo Framework as applied to biology and to technology Biomimetics &BioTriz) | # Comparative genomics of gene regulatory networks | ||
# Converging technologies ( Bits Atoms | # Evolution & Development & Ecology ( Evo Devo Evo Framework as applied to biology and to technology : Biomimetics &BioTriz) | ||
# Converging technologies ( Bits Atoms Neurons & Genes ) | |||
# Neuromorphic computing deep learning /machinelearning and modelling as applied to life sciences /sequence structures functions and roles | |||
==Useful links== | ==Useful links== | ||
http://www.cdc.gov/OD/ohs/biosecurity_training/ | |||
http://www.cdc.gov/OD/ohs/biosfty/bmbl5/bmbl5toc.htm | |||
*[[OpenWetWare:Welcome|Introductory tutorial]] | *[[OpenWetWare:Welcome|Introductory tutorial]] | ||
*[[Help|OpenWetWare help pages]] | *[[Help|OpenWetWare help pages]] | ||
| Line 36: | Line 43: | ||
* http://www.opbw.org/ | * http://www.opbw.org/ | ||
One of the major challenges ahead is Antibiotics resistance | One of the major challenges ahead is Antibiotics resistance | ||
How can this be circumvented Can | How can this be prevented or circumvented http://www.who.int/drugresistance/whonetsoftware/en/ | ||
Rephrasing: Can Synthetic Biology be of use in developing new antibiotics without the perils of horisontal gene transfer and resistance ? | |||
http://www.gmo-compass.org | |||
http://www.who.int/drugresistance/whonetsoftware/en/ | http://www.who.int/drugresistance/whonetsoftware/en/ | ||
http://www.fda.gov/Fdac/features/795_antibio.html | http://www.fda.gov/Fdac/features/795_antibio.html | ||
http://www.who.int/mediacentre/factsheets/fs194/en/ | http://www.who.int/mediacentre/factsheets/fs194/en/ | ||
Latest revision as of 03:06, 3 January 2019
I am a new member of OpenWetWare!
Contact Info
- Paul Anders Fronth Nyhus
- NorBioS
- SynBiOSyS
- Norwegian.Igem.Team
- Europe
- Email me through OpenWetWare
I work in the [Open LAB ] at XYZ University. I learned about OpenWetWare from The Longnow Foundation, and I've joined because I deem it necessary and warranted to establish a coherent analytical framework for understanding the long term risks in relation to genetic engeneering and voluntary codes of conduct for dealing proactively with Biorisks , Biosafety , Biosecurity and Biodiversity Acces Benefit Sharing issues in Synthetic Biology Metabolic engennering Combinatorial Genomics and genome editing .Herein included Economic, Ethical, Legal and Social Issues as to maximize benefits ( for whom ? ) and minimize potential negative risks and unintended consequences if not sheer luddism and complete rejection from civil society.
Discussing the options by inclusion and involvement of stakeholders sui generis:Cui Bene
Education
- Year, PhD, Institute
- Year, MS, Institute
- Year, BS, Institute
Research interests
- Comparative genomics of Aquaporins and gene regulation
- BioPatways2Bioprocess Green Chemistry Cell Free Systems and scaffolds
- MarineMicrobiomics Comparative genomics proteomics and metabolomics of Photosynthesis /E-Photosynthesis /Quantum Effects in Biology
- Comparative genomics of gene regulatory networks
- Evolution & Development & Ecology ( Evo Devo Evo Framework as applied to biology and to technology : Biomimetics &BioTriz)
- Converging technologies ( Bits Atoms Neurons & Genes )
- Neuromorphic computing deep learning /machinelearning and modelling as applied to life sciences /sequence structures functions and roles
Useful links
http://www.cdc.gov/OD/ohs/biosecurity_training/ http://www.cdc.gov/OD/ohs/biosfty/bmbl5/bmbl5toc.htm
- Introductory tutorial
- OpenWetWare help pages
- http://www.biosecuritycodes.org/
- http://www.synbiosafe.eu/
- http://www.biosafety.be/Menu/BiosEur.html
- http://www.patentlens.net/daisy/patentlens/patentlens.html
- http://www.opbw.org/
One of the major challenges ahead is Antibiotics resistance How can this be prevented or circumvented http://www.who.int/drugresistance/whonetsoftware/en/ Rephrasing: Can Synthetic Biology be of use in developing new antibiotics without the perils of horisontal gene transfer and resistance ? http://www.gmo-compass.org http://www.who.int/drugresistance/whonetsoftware/en/ http://www.fda.gov/Fdac/features/795_antibio.html http://www.who.int/mediacentre/factsheets/fs194/en/
